In this issue:
Association between TNF inhibitors and CNS diseases
Increased intracranial pressure and MOGAD
sGFAP and sNfL as biomarkers for MOGAD
Ocrelizumab on pregnancy and infant outcomes
Ravulizumab versus efgartigimod
The ENSEMBLE study
Long-term outcomes of anti- NMDAR
Clinical outcomes of generalised MG
Efficacy and safety of immunosuppressive therapies
Please login below to download this issue (PDF)